ClinicalTrials.Veeva

Menu

Long-term Pulmonary Outcomes After Infection With Sars-CoV-2

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Sars-CoV2
Covid19

Treatments

Diagnostic Test: Imaging of the lungs

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The objective of this study is to assess the long-term outcomes after hospital admission with Covid-19 with respect to pulmonary function, physical capacity, imaging, quality of life and socioeconomic outcomes.

Full description

Patients will be invited to follow-up visits 3 and 12 months after hospitalization with COVID19.

Inclusion will take place during 2020. We expect to enroll 180 non-ICU patients and 36 ICU patients.

Enrollment

218 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infection with Sars-CoV-2

Exclusion criteria

  • Unable to attend hospital visits due to frailty or severe disease
  • Unable to understand and complete questionnaires due to intellectual or language limitations / deficits

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems